Targeted Agents: Management of Dermatologic Toxicities

This information was originally presented on March 14, 2014, at the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.

Target Audience

This activity is designed to meet the educational needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Integrate into professional practice treatment strategies for management of dermatologic toxicities resulting from targeted agents
  • Diagnose and manage dermatologic toxicities caused by targeted agents in patients with cancer
Additional information
Supporters: 

Supported by educational grants from:

  • Genentech
  • Prometheus Laboratories Inc.
Course summary
Available credit: 
  • 0.75 Participation
  • 0.69 Nurse
  • 0.75 Pharmacist
  • 0.75 Physician
Course opens: 
04/29/2014
Course expires: 
04/29/2015
Cost:
$0.00
Part of: 
Recorded Presentations from the NCCN 19th Annual Conference: Skin Malignancies

Barbara Burtness, MD
Fox Chase Cancer Center

Available Credit

  • 0.75 Participation
  • 0.69 Nurse
  • 0.75 Pharmacist
  • 0.75 Physician

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
  • Adobe Reader for certificate viewing/printing